Back to results

Emergent Biosolutions

Distributor

Warning letter

Non-Compliance Report

Headquarters

United States of America

Sites

United States of America

FDA warning letter

Issue date

10 Aug 2022

Issuing office

Division of Pharmaceutical Quality Operations I

Posted date

16 Aug 2022

Subject

CGMP/Finished Pharmaceuticals/Adulterated

Products & Services

Drugs

Closeout letter

Issue date

4 Oct 2023